CIK 0001971387 · <br>Emerging growth company
Liminatus Pharma, Inc.
Sign in to watch- Ticker
- LIMN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 213-273-5453
- Business address
- 12611 HIDDENCREEK WAY, UNIT C, CERRITOS, CA, 90703
- Former names
- Iris Parent Holding Corp.
Securities
- LIMN Class A Common Stock Nasdaq
- LIMNW Warrants Nasdaq
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4 Deal Registration Statement - Business Combination
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
Page 6 of 6 · 109 filings